Send Inquiry

Request To Call Back

Luliconazole Powder Api

Name: Luliconazole Powder Api
Brand: NR LIFE CARE
Price: 26000 INR
Availability: InStock

Price 26000 INR/ Kilograms

Get a Price/Quote

MOQ : 100 Kilograms

Luliconazole Powder Api Specification

Molecular Formula
C14H9Cl2N3O2

Smell
Odorless

Molecular Weight
324.15 g/mol

Structural Formula
Available on request

Melting Point
143-147C

HS Code
29420090

Loss on Drying
0.5%

Storage
Store in a cool, dry place, protected from light

Color
White

Shelf Life
5 years from manufacture date

Boiling point
Not applicable (decomposes)

Taste
Bitter

Poisonous
Non-poisonous under recommended use

Solubility
Slightly soluble in methanol, ethanol; Insoluble in water

Particle Size
D90 <10 microns

Heavy Metal (%)
10 ppm

EINECS No
None assigned

Medicine Name
Luliconazole Powder API

Chemical Name
(RS)-4-{(2R*,4S*)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl}1H-imidazole

CAS No
877399-52-5

Type
Pharmaceutical Raw Material

Grade
Pharma Grade

Usage
Topical antifungal agent for skin infections

Purity(%)
99%

Appearance
White to off-white powder

Physical Form
Powder

Bulk Density
0.35-0.45 g/cm3

Regulatory Status
DMF available on request

Assay
99% by HPLC

Polymorph
Form-I

Residual Solvents
As per ICH Q3C guidelines

Certificate of Analysis
Available with each batch

Packaging Size
Customizable (1g, 5g, 10g, 100g, 500g, 1kg)

Safety Data Sheet
Supplied upon request

Transport Conditions
Keep container tightly closed, avoid extreme temperature

Manufacturing Process
Synthetic

Identification
Complies with USP/EP requirements

Related Substances
Total impurities 1.0%

Microbial Limit
Meets pharmacopeial standards

Luliconazole Powder Api Trade Information

Minimum Order Quantity
100 Kilograms

FOB Port
NHAVA SHEVA

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
1000 Kilograms Per Day

Delivery Time
5 Days

Sample Policy
If order is confirmed we will reimburse the sample cost

Packaging Details
25kg

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

Certifications
COA

Luliconazole Powder Api About

Luliconazole, trade names Luzu among others, is an imidazole antifungal medication. As a 1 Percent topical cream, It is indicated for the treatment of athletes foot, jock itch, and ringworm caused by dermatophytes such as Trichophyton rubrum, Microsporum gypseum and Epidermophyton floccosum.

Specification

Country of Origin	Made in India
Composition	Luliconazole
Packaging Size	25 Kg
Type of API	Anti Infective API
Pack Type	Bag
Prescription/Non prescription	Prescription
From	Powder

Superior Quality Assurance

Luliconazole Powder API is meticulously tested to meet high standards, such as a minimum assay of 99% by HPLC and total impurities not exceeding 1.0%. Every batch undergoes thorough identification processes, complying with USP/EP requirements, and is supported by a Certificate of Analysis. These measures guarantee reliability, safety, and efficacy for pharmaceutical applications.

Flexible Packaging and Supply Chain

The API is available in customizable sizes from 1g to 1kg, catering to both research and commercial needs. Logistics are managed expertly by distributors, exporters, and suppliers across India, ensuring timely delivery. Transport conditions are strictly controlledcontainers are kept tightly closed, and exposure to extreme temperatures is avoided to maintain product integrity.

Comprehensive Regulatory and Safety Documentation

Each shipment includes crucial documentation such as a Safety Data Sheet and a Certificate of Analysis. For regulatory purposes, Drug Master Files (DMF) are accessible on request. These resources facilitate seamless import, export, and registration processes, making Luliconazole Powder API a reliable choice for global pharmaceutical markets.

FAQs of Luliconazole Powder Api:

Q: How is the quality and purity of Luliconazole Powder API verified before distribution?

A: Quality and purity are validated using HPLC assay, confirming at least 99% content, alongside compliance with USP/EP identification standards and impurity profiling. Each batch undergoes rigorous pharmacopeial microbial testing and satisfies ICH Q3C guidelines for residual solvents, with results documented in the Certificate of Analysis.

Q: What packaging sizes are available for ordering Luliconazole Powder API, and can they be customized?

A: Luliconazole Powder API is offered in a variety of packaging options, including 1g, 5g, 10g, 100g, 500g, and 1kg sizes. Packaging can be customized based on specific customer requirements to suit both laboratory and commercial scale quantities.

Q: When and where is the Certificate of Analysis and Safety Data Sheet provided for this product?

A: The Certificate of Analysis is provided with every batch, detailing the analytical results and compliance status. A Safety Data Sheet is supplied upon request to guide safe handling and usage procedures throughout the supply chain.

Q: What are the recommended storage and transport conditions for Luliconazole Powder API?

A: The product should be kept in tightly closed containers and protected from extreme temperatures during transportation and storage to preserve its stability and quality. These controlled conditions are closely monitored by the supplier to ensure integrity upon delivery.

Q: What is the benefit of using Luliconazole Powder API from this manufacturer in India?

A: Choosing this source provides assurance of stringent quality standards, customizable packaging, regulatory complianceincluding DMF supportand documented safety, making it an ideal option for consistent and reliable pharmaceutical manufacturing processes.

Q: How does the manufacturer ensure regulatory and documentation compliance for global markets?

A: The supplier provides comprehensive regulatory documentation, including Certificates of Analysis and DMF availability on request, streamlining importation and registration processes for international clients. Adherence to USP/EP, pharmacopeial, and ICH guidelines further supports compliance.